BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2562360)

  • 21. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
    Roskoski R
    Pharmacol Res; 2018 Mar; 129():65-83. PubMed ID: 29408302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines.
    Nistér M; Claesson-Welsh L; Eriksson A; Heldin CH; Westermark B
    J Biol Chem; 1991 Sep; 266(25):16755-63. PubMed ID: 1653246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action and in vivo role of platelet-derived growth factor.
    Heldin CH; Westermark B
    Physiol Rev; 1999 Oct; 79(4):1283-316. PubMed ID: 10508235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class.
    Gronwald RG; Grant FJ; Haldeman BA; Hart CE; O'Hara PJ; Hagen FS; Ross R; Bowen-Pope DF; Murray MJ
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3435-9. PubMed ID: 2835772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-derived growth factors: a family of isoforms that bind to two distinct receptors.
    Heldin CH; Westermark B
    Br Med Bull; 1989 Apr; 45(2):453-64. PubMed ID: 2557116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of PDGF alpha- and beta-receptors in rat arterial smooth muscle cells is phenotype and growth state dependent.
    Sjölund M; Rahm M; Claesson-Welsh L; Sejersen T; Heldin CH; Thyberg J
    Growth Factors; 1990; 3(3):191-203. PubMed ID: 2173936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional aspects of platelet-derived growth factor and its role in the pathogenesis of glioblastoma.
    Betsholtz C; Nistér M; Rorsman F; Heldin CH; Westermark B
    Mol Chem Neuropathol; 1989 Feb; 10(1):27-36. PubMed ID: 2544195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells.
    Keating MT; Williams LT
    Science; 1988 Feb; 239(4842):914-6. PubMed ID: 2829358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin-like domain 4-mediated receptor-receptor interactions contribute to platelet-derived growth factor-induced receptor dimerization.
    Omura T; Heldin CH; Ostman A
    J Biol Chem; 1997 May; 272(19):12676-82. PubMed ID: 9139724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-derived growth factor: roles in normal and v-sis transformed cells.
    Deuel TF; Kimura A; Maehama S; Tong BD
    Cancer Surv; 1985; 4(4):633-53. PubMed ID: 2824043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis.
    Rönnstrand L; Arvidsson AK; Kallin A; Rorsman C; Hellman U; Engström U; Wernstedt C; Heldin CH
    Oncogene; 1999 Jun; 18(25):3696-702. PubMed ID: 10391677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
    Keating MT; Escobedo JA; Fantl WJ; Williams LT
    Trans Assoc Am Physicians; 1988; 101():24-32. PubMed ID: 2480016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
    Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Function, molecular structure and gene expression regulation of Platelet-derived growth factor].
    Kaji K
    Nihon Rinsho; 1992 Aug; 50(8):1902-9. PubMed ID: 1433982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a heterodimeric receptor complex.
    Rupp E; Siegbahn A; Rönnstrand L; Wernstedt C; Claesson-Welsh L; Heldin CH
    Eur J Biochem; 1994 Oct; 225(1):29-41. PubMed ID: 7523122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling.
    Yu JC; Gutkind JS; Mahadevan D; Li W; Meyers KA; Pierce JH; Heidaran MA
    J Cell Biol; 1994 Oct; 127(2):479-87. PubMed ID: 7929590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
    Kochhar KS; Linnekin D; Iyer AP
    Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor: mechanism of action and relation to oncogenes.
    Heldin CH; Betsholtz C; Johnsson A; Nistér M; Ek B; Rönnstrand L; Wasteson A; Westermark B
    J Cell Sci Suppl; 1985; 3():65-76. PubMed ID: 3011826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimeric alpha- and beta-platelet-derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the alpha-PDGF receptor that determine PDGF-AA binding specificity.
    Heidaran MA; Pierce JH; Jensen RA; Matsui T; Aaronson SA
    J Biol Chem; 1990 Nov; 265(31):18741-4. PubMed ID: 2172231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding.
    Ekman S; Thuresson ER; Heldin CH; Rönnstrand L
    Oncogene; 1999 Apr; 18(15):2481-8. PubMed ID: 10229199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.